Related by context. All words. (Click for frequent words.) 67 chemopreventive agent 67 antiangiogenic 65 HDAC inhibition 65 cytoprotective 65 inhibit angiogenesis 65 mTOR inhibitors 65 anti angiogenic drugs 65 inhibit metastasis 65 JAK inhibitors 64 HuLuc# 64 immunomodulation 64 inhibiting tumor 64 antiangiogenesis 64 SERMs 64 MEK inhibitors 64 anticancer therapy 64 #ME# 64 VEGF receptor 64 molecularly targeted 64 BRAF inhibitors 64 vivo potency 63 PKCi 63 TGF β 63 tubulin inhibitor 63 HbF 63 uric acid lowering 63 selective inhibition 63 p# activation 63 TNFa 63 Symadex 63 VEGF inhibitors 63 VDAs 63 neuro protective 63 anti angiogenic agents 63 Th2 cytokines 63 Tavocept 63 IAP inhibitor 62 antiangiogenic agents 62 mTOR inhibition 62 PARP inhibitors 62 hedgehog pathway 62 cediranib 62 cytostatic 62 corticosteroid dexamethasone 62 insulin sensitizing 62 PPARg 62 epigenetic therapies 62 treating neuropathic pain 62 Akt1 62 metastatic lesions 62 imatinib Gleevec 62 biologic therapeutics 62 Onconase 62 NFκB 62 MAXY G# 62 insulin analogues 62 immune modulatory 62 thymidylate synthase TS 62 mutated K ras 62 XmAb# 62 HIF 1α 62 inhibiting angiogenesis 62 Panzem 62 immune modulating 62 YONDELIS 62 antiangiogenic drugs 62 Dasatinib 62 casein kinase 62 NF KB 62 Treg cell 62 AEG# 62 chemotherapeutic treatments 61 A3 adenosine receptor 61 TNFα 61 standard chemotherapy regimens 61 PGE2 61 JAK3 61 PI3K inhibitors 61 PHD2 61 investigational therapies 61 immune modulator 61 immuno modulatory 61 radionuclide therapy 61 FGFR 61 antiinflammatory 61 AMPK activators 61 neurotrophic 61 Aplidin 61 DHFR 61 carcinoids 61 DACH platinum 61 hormone gastrin 61 epithelial tissues 61 cathepsins 61 chemoprotective 61 Smac mimetic 61 TOCOSOL Camptothecin 61 enzyme inhibitors 61 PI3 kinase 61 vascular disrupting agents 61 Abiraterone acetate 61 TMEM#B 61 RKIP 61 anti CD3 61 effector functions 61 neoplastic transformation 61 endostatin 61 CTAP# Capsules 61 ACh 61 IGF IR 61 vidofludimus 61 dasatinib Sprycel 61 c MET 61 oncoprotein 61 heparanase 61 vorinostat 61 Gleevec resistant 61 potent antiproliferative 61 PPARγ 61 incyclinide 61 molecularly targeted therapies 61 recombinant erythropoietin 61 ADAMTS# 60 cardiac contractility 60 eIF 4E 60 HCV protease inhibitors 60 epithelial tumors 60 ACAT2 60 EGFr 60 Wnt signaling pathway 60 Trastuzumab 60 histone deacetylases 60 act synergistically 60 pro angiogenic 60 TGF ß1 60 Panzem R NCD 60 lipid lowering therapies 60 LY# [003] 60 HIF 1alpha 60 activate p# 60 anticancer activity 60 mevalonate 60 Akt activation 60 MMP inhibitors 60 haematopoietic 60 antisense RNA 60 anticancer therapies 60 Aviptadil 60 fulvestrant 60 CCR9 antagonist 60 Vandetanib 60 fibrin deposition 60 oncogenesis 60 neovascularization 60 effector function 60 nitric oxide synthase 60 maximally tolerated 60 miR #a [002] 60 ACE2 60 Imatinib 60 druggable target 60 gastrin 60 nucleoside analogs 60 growth hormone secretion 60 rhIL 7 60 inhibit viral replication 60 HDAC2 60 Interferon alpha 60 MDS AML 60 RANKL 60 TGR5 60 FGF2 60 CBLC# 60 NADPH oxidase 60 fibrotic disease 60 preclinically 60 delta isoform 60 bone metastasis 60 RIP1 kinase 60 ubiquinol 60 endocrine therapies 60 druggable 60 endoxifen 60 IRX 2 60 ERK1 2 60 RAS RAF MEK 60 vitamin D analogs 60 mAbs 60 renin inhibitors 60 anti mitotic 60 NF kB pathway 60 cancer immunotherapies 60 myelofibrosis polycythemia vera 60 neurotrophic factors 60 sirtuin enzymes 60 chemosensitivity 60 predictive biomarkers 60 PlGF 60 EGFR inhibitors 60 sarcosine 60 ixabepilone 60 Hsp# inhibition 60 angiogenesis inhibitor 60 pertuzumab 60 cytoreduction 60 c MYC 60 ESBA# 60 Aurora kinase 60 PI3K AKT 60 MAPK pathway 60 Lisofylline 60 CA4P 60 RLY# 60 idarubicin 60 PSN# [002] 60 p# MAP kinase 60 Interferon beta 60 FGFs 60 TRV# [001] 60 SNT MC# 60 calcineurin 60 HER2 positive cancers 59 Stat5 59 antiapoptotic 59 PSMA ADC 59 Tasimelteon 59 oncomodulin 59 SGLT2 59 plasma kallikrein 59 immunomodulatory 59 colorectal carcinoma 59 ERBB2 59 antimetastatic 59 antiresorptive 59 Mipomersen 59 SERCA2a 59 NKG2D 59 lapatinib Tykerb 59 immunomodulatory effects 59 chemoresistant 59 Nanobody ® 59 riociguat 59 Kinase inhibitors 59 proteasome inhibitors 59 dephosphorylation 59 antibody mediated 59 relapsed ovarian cancer 59 IL 1ß 59 erlotinib Tarceva 59 small molecule activators 59 p#NTR 59 antiangiogenic therapy 59 chemotherapeutic drug 59 novel VDA molecule 59 BrachySil TM 59 MGd 59 siRNA therapeutics 59 Eg5 59 deacetylase inhibitors 59 potentiator 59 antiproliferative effects 59 ADAM# 59 anakinra 59 talabostat 59 selectively inhibited 59 PDGFR 59 basal cell nevus syndrome 59 uPA 59 nAChR 59 norepinephrine reuptake inhibition 59 ERK pathway 59 antiproliferative 59 tumor vascularization 59 secondary hyperparathyroidism 59 Notch1 59 otelixizumab 59 trastuzumab Herceptin 59 SOCS1 59 RhuDex ® 59 IL #p# 59 Cytolin R 59 glucagon receptor 59 HER2 receptor 59 neurite outgrowth 59 IMC A# 59 immunotoxins 59 thalidomide Thalomid 59 PKC alpha 59 tumor necrosis 59 HIF 1a 59 PXD# 59 secretory pathway 59 transgene expression 59 Archexin 59 Hedgehog signaling 59 FGFR3 59 angiogenesis inhibitors 59 CCX# 59 TGF beta signaling 59 isoform selective 59 coagulation cascade 59 antimetabolite 59 FLT3 59 intracellular signal transduction 59 Panzem R 59 PEG SN# 59 Factor VIIa 59 tumor hypoxia 59 Ceflatonin 59 p# inhibitors 59 drug GAP #B# 59 receptor inhibitor 59 ALK inhibitors 59 pharmacologic intervention 59 thetreatment 59 potentiating 59 immune reconstitution 59 NF kappaB pathway 59 histone deacetylase HDAC 59 CYT# potent vascular disrupting 59 Campath ® 59 oral antidiabetic 59 PDE4 inhibitors 59 thromboxane A2 59 systemic toxicity 59 humanized monoclonal antibodies 59 tumor suppressor protein 59 p# MAPK 59 therapeutic monoclonal antibody 59 IGFBP 59 pharmacokinetic interactions 59 FGFR1 59 B7 H3 59 taxane chemotherapy 59 biologic pathways 59 cytotoxic therapies 59 tumor metastasis 59 CFTR inhibitors 59 inhibit EGFR 59 cardiotoxic 59 TXNIP 59 Litx 58 Vidaza azacitidine 58 proteasome inhibitor 58 serotonin synthesis 58 EGFR tyrosine kinase inhibitors 58 Inhaled nitric oxide 58 Preclinical studies suggest 58 tyrosine kinase inhibitor 58 hypoxia inducible factor 58 TroVax ® 58 insulin analogs 58 INCB# [001] 58 COX enzymes 58 skeletal metastases 58 EGFR pathway 58 cytokine IL 58 neovascularisation 58 rEV# 58 PIGF 58 immunodeficiency disorders 58 EGF receptor 58 lytic 58 pegfilgrastim 58 JAK1 58 IL 1beta 58 receptor tyrosine kinase inhibitor 58 anticancer agents 58 Amplimexon 58 pegylated liposomal doxorubicin 58 immune modulators 58 JAK#/JAK# 58 cytolytic 58 telomere dysfunction 58 eniluracil 58 GSK3B 58 HSP# inhibitor 58 Smac mimetics 58 activin 58 suppresses tumor 58 cell signaling pathways 58 TET2 58 JAK2 inhibitor 58 antiandrogen 58 chemo resistant 58 lenalidomide dexamethasone 58 interferon beta therapy 58 CXCR4 receptor 58 adrenergic receptors 58 Nedd4 58 tyrosine phosphorylation 58 calcineurin inhibitors 58 Avastin Tarceva 58 Bleomycin 58 cytokines interleukin 58 p# mutation 58 hematological indications 58 PIK3CA 58 mertansine 58 Azedra 58 p# mutations 58 multitargeted 58 proliferative disorders 58 M1 macrophages 58 chemopreventive agents 58 TAp# 58 Nanobodies 58 partial agonist 58 PI3K/mTOR 58 immune suppressing 58 FOXO3a 58 oncolytic 58 Chk1 inhibitors 58 Notch pathway 58 breast cancer metastasis 58 metaglidasen 58 renal fibrosis 58 chemotherapeutic agents 58 oncoproteins 58 griseofulvin 58 gefitinib Iressa 58 Intravenous CP 58 Zolinza 58 enzyme inhibitor 58 Enkephalin 58 pancreatic islet 58 CDP# 58 toxic amyloid beta 58 PDGF receptor 58 fusion enhancers 58 thrombopoietin 58 trabectedin 58 NNRTIs 58 immune stimulatory 58 hedgehog signaling 58 β catenin 58 GRP# 58 amyloid deposition 58 CYP #A# 58 anticlotting 58 marketed EGFR 58 neuroregenerative 58 NPD1 58 anti CD3 antibody 58 YONDELIS R 58 flavopiridol 58 5 HT2C receptor 58 Nicole Onetto MD 58 androgen receptor signaling 58 Nanobody 58 RANK ligand 58 endoglin 58 Nanobodies ® 58 Virulizin ® 58 NTDDS 58 mimetics 58 ulimorelin 58 #HT#A 58 inducible nitric oxide synthase 58 L dopa 58 IFNs 58 PTEN protein 58 convenient dosing regimens 58 TGF alpha 58 Squalamine 58 hematopoietic cells 58 antithrombotic agents 58 EGFR receptor 58 anti fibrotic 58 platelet activation 58 radiotherapeutic 58 inhibit tumor 58 triphendiol 58 prostate carcinogenesis 58 osteoclast formation 58 kidney urologic 58 gemcitabine Gemzar 58 Hedgehog pathway 58 osteoclast 58 fibrinolytic 58 HIV protease inhibitors 58 signaling cascades 58 resolvins 58 poly ADP ribose polymerase 58 fibrate drugs 58 Rasagiline 58 HSP# inhibitors 58 immunotoxin 58 docetaxel Taxotere ® 58 antidiabetic 58 adrenal hormone 58 costimulation 58 prostaglandin D2 58 PDGF alpha receptor 58 MEK ERK 58 cyclooxygenase 58 curative therapy 58 immunosuppressive regimens 58 CaM kinase II 58 peptide antigens 58 histone deacetylase inhibitor 58 cellular pathways 58 CRAC channel 58 thrombolytic agents 58 Fc receptors 58 MIF protein 58 PROCHYMAL 58 BRAF V# mutation 58 Tamibarotene 58 E#F# 58 TNF alpha inhibitor 58 Herceptin trastuzumab 58 tumorigenesis 58 U1 Adaptors 58 cisplatin resistant 58 antitumor effects 58 Fibroblast Growth Factor Receptor 58 HCV replication 57 Fc receptor 57 enzastaurin 57 Hedgehog inhibitor 57 natriuretic peptides 57 phosphate S1P 57 PDE7 inhibitors 57 lymphangiogenesis 57 tumorigenic 57 tamoxifen Nolvadex ® 57 TGF ß 57 immunostimulatory effects 57 neuronal stem cells 57 cytotoxics 57 ARF1 57 clusterin 57 LTB4 57 antiplatelet therapies 57 RNA silencing 57 GATA3 57 HMG CoA reductase 57 NKT cells 57 MAP kinase 57 TNFalpha 57 targeted radiotherapeutic 57 Exelixis XL# 57 protein kinase inhibitor 57 anticancer treatments 57 amyloidogenic 57 GSK3 57 Fludara ® 57 CGRP 57 senescent cells 57 Th# cells 57 inhibitory neurotransmitters 57 synthetic retinoid 57 regorafenib 57 PDE4 inhibitor 57 TNF blocker therapy 57 induce apoptosis 57 Angiotensin converting enzyme 57 eflornithine 57 Gleevec imatinib mesylate 57 HER2 neu 57 cytokine signaling 57 orally bioavailable mimics 57 EphA2 57 myeloproliferative disorders 57 CB2 receptor 57 xanthine oxidase inhibitor 57 androgen receptor AR 57 pulmonary metastases 57 glycosylation profile 57 p# pathway 57 Rituxan MabThera 57 intranasal delivery 57 anti angiogenesis 57 EphB2 57 ApoA1 57 intracellular proteins 57 HDAC inhibitors 57 bevacizumab Avastin ® 57 antidiabetic therapy 57 PKM2 57 leukemic stem cells 57 micro RNAs 57 mitochondrial fusion 57 liver metastasis 57 IV bisphosphonates 57 erlotinib Tarceva ® 57 ganetespib 57 synovial cells 57 TPO receptor 57 mTOR mammalian target 57 TELINTRA 57 immunoregulatory 57 colorectal tumors 57 Apo2L 57 pancreatic endocrine 57 TNF α 57 androgen receptors 57 anti angiogenic therapy 57 iNOS 57 FVIIa 57 MDM2 57 beta catenin protein 57 VEGFR2 57 histone deacetylation 57 antidiabetic drugs 57 curative therapies 57 blood clot dissolving 57 sd rxRNA 57 systemic antifungal 57 mutated p# 57 Cyclin D1 57 cytotoxic agents 57 Erlotinib 57 IDH mutations 57 cilengitide 57 downregulating 57 Resten NG 57 N Myc 57 agents ESAs 57 Epothilones 57 Gefitinib 57 Revlimid lenalidomide 57 MetAP 57 triphosphate 57 angiogenesis inhibition 57 neuronal dysfunction 57 micronuclei 57 lowering blood glucose 57 S#P# 57 PARP inhibition 57 CETP inhibition 57 Pertuzumab 57 collagenase 57 alkylating agent 57 FBPase 57 anti CD# antibodies 57 allergic inflammation 57 protein tyrosine phosphatases 57 factor PlGF 57 sorafenib Nexavar 57 collagen synthesis 57 intravenous cyclophosphamide 57 PET tracers 57 epothilone 57 inhaled anesthetics 57 durable remissions 57 KIT mutations 57 tumor microenvironment 57 Degarelix 57 neuropilin 57 tumor vascular disrupting 57 anticancer therapeutics 57 therapeutic regimens 57 suppressor gene 57 5FU 57 kinase inhibition 57 cytotoxic 57 cell lysis 57 prostatic tissue 57 oral antiviral 57 survivin 57 induce angiogenesis 57 osteoclast activity 57 panobinostat 57 OXi# 57 microtubule targeting 57 anticancer agent 57 colorectal lung 57 premalignant lesions 57 intensive lipid lowering 57 Vidofludimus 57 plasminogen activators 57 IMiDs 57 lipid synthesis 57 Combination therapy 57 lung metastasis 57 acadesine 57 ENMD # 57 GAP #B# 57 bortezomib Velcade 57 selectively inhibit 57 CIMZIA ™ 57 Cdc7 57 BRAF mutation 57 sGC 57 taxane refractory 57 β amyloid 57 HDAC6 57 oral prodrug 57 Anti angiogenic 57 IFN γ 57 glial scar 57 ocular disorders 57 4E BP1 57 thymosin 57 imatinib resistance 57 lung fibrosis 57 seliciclib 57 pDCs 57 MyVax 57 intracellular pathways 57 leukemic cell 57 lung epithelium 57 GIST tumors 57 vascular disrupting 57 therapeutically relevant 57 vascular endothelial 57 PLX cells 57 C5a 57 rBChE 57 IAP inhibitors 57 Tyrima 57 PI3 K 57 histone deacetylase inhibitors 57 chronic viral infections 57 neovascular 57 K + ATPase 57 samalizumab 57 nutlin 57 interferons 57 dosing frequency 57 pathophysiological mechanisms 57 B7 H1 57 micrometastases 57 metastatic colorectal 57 matrix metalloproteinases 57 dexpramipexole 57 novel anticancer 57 antiviral cytokines 57 WT1 57 CCR9 57 tumor angiogenesis 57 oncogenic transformation 57 monoclonal antibody MAb 57 Akt3 57 antiarrhythmic 57 Src inhibitors 57 immunomodulating 57 OMP #R# 57 LNP formulations 57 therapeutic peptide 57 QVAR 57 metastatic RCC 57 Vascular Endothelial Growth 57 immunosuppressant therapies 57 xenograft models 57 Octreotide 57 PEGylated 57 CCN2 57 IL# PE#QQR 57 LHRH antagonists 57 amikacin 57 HuR 57 IRHs 57 prostaglandin E2 57 Solulin 57 renin angiotensin 57 eicosanoid 57 independent prognostic marker 57 TGF beta pathway 57 antithrombotic 57 albumin bound paclitaxel 57 immunological diseases 57 Wnt pathway 57 sphingosine kinase 57 OMP #M# 57 UsiRNAs 57 TG# [003] 57 neuroprotection 57 PET molecular imaging 57 coronary vasodilation 57 FOLFOX chemotherapy 57 protein kinase C 57 PNH patients 57 PPAR γ 57 serine proteases 57 Six3 57 Kinoid 57 VEGF vascular endothelial 57 benfotiamine 56 Arsenic trioxide 56 mesenchymal cell 56 beta subunit 56 TLR8 56 Anthracycline 56 small molecule tyrosine 56 biologic therapy 56 Cyclin E 56 ADME properties 56 eNOS 56 molecular biomarkers 56 MEK1 56 blood clot dissolver 56 nucleosides 56 indibulin 56 CEACAM1 56 Axitinib 56 aberrant activation 56 cyclin dependent kinases 56 beta Estradiol 56 osteopontin 56 EP #R 56 inducing apoptosis 56 Fc fusion protein 56 ASONEP 56 velafermin 56 omega interferon 56 airway hydration 56 mutated KRAS gene 56 Smoothened 56 androgen receptor 56 CaM kinase 56 interferon IFN 56 vinca alkaloids 56 pro apoptotic 56 kinase inhibitors 56 pharmacological chaperone 56 DCVax R 56 collagen degradation 56 neuronal signaling 56 ionotropic 56 TKM ApoB 56 relapsed ALL 56 osteosarcomas 56 anti androgen 56 vanilloid receptor 56 microtubule dynamics 56 LMWHs 56 glioma cells 56 granulocyte 56 DXL# 56 ProSavin 56 PSN# [001] 56 stapled peptides 56 excess glutamate 56 GRK2 56 5 lipoxygenase 56 P selectin 56 pleiotropic 56 milatuzumab 56 chemokine receptor 56 Trofex 56 thrombolytics 56 BMP4 56 chemoresistance 56 tenascin C 56 inhibitory effects 56 cell adhesion molecule 56 ErbB3 HER3 56 nucleoside analog 56 clevidipine 56 mTORC1 56 chromosomal instability 56 protein tyrosine phosphatase 1B 56 radioiodine therapy 56 corticosteroid therapy 56 pigment epithelium derived 56 deforolimus 56 HER2 positive metastatic breast 56 prognostic markers 56 neuroprotectant 56 melanoma tumors 56 cellular immunotherapy 56 RNAi therapeutic targeting 56 malignant transformation 56 Bezielle 56 HDACs 56 ASC J9 56 oncogenic mutations 56 colorectal tumor 56 trastuzumab Herceptin ® 56 monocyte chemoattractant protein 56 Src kinase 56 IDH1 56 anti leukemic 56 antibody cytokine 56 tissue fibrosis 56 teriflunomide 56 EGF receptors 56 Fas ligand 56 HER2 expression 56 LRP6 56 proto oncogene 56 glycolytic 56 LRP1 56 MAPK signaling pathway 56 remyelination 56 monoclonal antibody therapies 56 anti TNFs 56 canakinumab 56 uricase 56 systemic immunosuppressive drugs 56 BCR ABL inhibitors 56 oral anticancer 56 NMDA antagonist 56 IGF 1R 56 HER2 receptors 56 adult neurogenesis 56 prodrugs 56 anti resorptive 56 Caelyx 56 Velcade bortezomib 56 TGF beta1 56 elastase 56 STAT3 56 VEGF expression 56 microtubule inhibitor 56 microvascular disease 56 antitumoral 56 adipose cells 56 Advagraf 56 PDE#A 56 cytotoxic chemotherapy 56 KL4 surfactant 56 CDK4 56 FasL 56 clonogenic 56 NEUGENE 56 serum phosphate 56 cardiac fibroblasts 56 TGFß 56 tipranavir 56 renin inhibition 56 inflammatory cascade 56 neuronal nicotinic receptors NNRs 56 alpha interferon 56 antitumour 56 TLR8 agonist 56 metabolic enzymes 56 cytotoxic T lymphocyte 56 pan HDAC inhibitor 56 P#X# 56 leukaemic stem cells 56 neuroinflammation 56 liposomal doxorubicin 56 overlapping toxicities 56 antiemetics 56 immuno suppressive 56 VEGF protein 56 serum phosphorus levels 56 camptothecin 56 CGEN # 56 galanin 56 IGFBP2 56 cathepsin K 56 glioblastoma tumor 56 Smad3 56 HGS# 56 procaspase 3 56 mitotic progression 56 N cadherin 56 incretins 56 lymphoid organs 56 ReN# 56 5 HT2A receptor 56 EndoTAG TM 56 LT NS# 56 druggable targets 56 thrombin receptor 56 hematopoietic blood 56 substrates inhibitors 56 MYDICAR ® 56 direct thrombin inhibitors 56 inhibit tumor angiogenesis 56 endogenous ligands 56 galectin 56 small molecule inhibitors 56 targeting CD# 56 nicotinic alpha 7 56 EBV infection 56 caveolin 1 56 p# inhibitor 56 ligand TRAIL 56 aromatase 56 COMT inhibitors 56 PTPN# 56 potent anticancer 56 autoantibody levels 56 selective inhibitors 56 Lixivaptan 56 iPSC 56 γ secretase 56 immunostimulatory 56 glutamate receptors 56 SOD1 56 divide uncontrollably 56 Cloretazine 56 OGG1 56 vascular disrupting agent 56 Clusterin 56 Cisplatin 56 RAS blockers 56 incretin 56 nephrotoxicity 56 GeneICE 56 DCCR 56 antitumor immunity 56 myofibroblast